Literature DB >> 31010563

Drugs for the Prevention and Treatment of Sepsis in the Newborn.

Sagori Mukhopadhyay1, Kelly C Wade1, Karen M Puopolo2.   

Abstract

Antimicrobial medications are the most commonly used medications in the neonatal intensive care unit. Antibiotics are used for infection prophylaxis, empiric treatment, and definitive treatment of confirmed infection. The choice of medication should be informed by the epidemiology and microbiology of infection in specific clinical scenarios and by the clinical condition of the infant. Understanding evolving pathogen susceptibility to antimicrobials and key pharmacotherapy determinants in neonates can inform optimal antibiotic use.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotics; Newborn; Prophylaxis; Sepsis

Mesh：

Substances：

Year:  2019        PMID： 31010563      PMCID： PMC6485941          DOI： 10.1016/j.clp.2019.02.012

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN： 0095-5108            Impact factor:   3.430


  82 in total

1.  Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.

Authors:  Jennifer S McDanel; Eli N Perencevich; Daniel J Diekema; Loreen A Herwaldt; Tara C Smith; Elizabeth A Chrischilles; Jeffrey D Dawson; Lan Jiang; Michihiko Goto; Marin L Schweizer
Journal:  Clin Infect Dis       Date:  2015-04-21       Impact factor: 9.079

2.  Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.

Authors:  Aline Fuchs; Monia Guidi; Eric Giannoni; Dominique Werner; Thierry Buclin; Nicolas Widmer; Chantal Csajka
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

Review 3.  Antibiotic synergism and antimicrobial combinations in clinical infections.

Authors:  G M Eliopoulos; R C Moellering
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

4.  Chromosomally and Extrachromosomally Mediated High-Level Gentamicin Resistance in Streptococcus agalactiae.

Authors:  Parham Sendi; Martina Furitsch; Stefanie Mauerer; Carlos Florindo; Barbara C Kahl; Sarah Shabayek; Reinhard Berner; Barbara Spellerberg
Journal:  Antimicrob Agents Chemother       Date:  2016-01-04       Impact factor: 5.191

5.  Conventional Versus Prolonged Infusion of Meropenem in Neonates With Gram-negative Late-onset Sepsis: A Randomized Controlled Trial.

Authors:  Abd Elazeez Shabaan; Islam Nour; Heba Elsayed Eldegla; Nehad Nasef; Basma Shouman; Hesham Abdel-Hady
Journal:  Pediatr Infect Dis J       Date:  2017-04       Impact factor: 2.129

Review 6.  Management of Neonates Born at ≥35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.

Authors:  Karen M Puopolo; William E Benitz; Theoklis E Zaoutis
Journal:  Pediatrics       Date:  2018-12       Impact factor: 7.124

7.  Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

Authors:  Zhiping Li; Yewei Chen; Qin Li; Di Cao; Wenjing Shi; Yun Cao; Dan Wu; Yiqing Zhu; Yi Wang; Chao Chen
Journal:  Eur J Clin Pharmacol       Date:  2013-01-26       Impact factor: 2.953

8.  Ampicillin prevents intrapartum transmission of group B streptococcus.

Authors:  M D Yow; E O Mason; L J Leeds; P K Thompson; D J Clark; S E Gardner
Journal:  JAMA       Date:  1979-03-23       Impact factor: 56.272

9.  Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.

Authors:  Stephen P Bergin; Joshua T Thaden; Jessica E Ericson; Heather Cross; Julia Messina; Reese H Clark; Vance G Fowler; Daniel K Benjamin; Christoph P Hornik; P Brian Smith
Journal:  Pediatr Infect Dis J       Date:  2015-09       Impact factor: 3.806

10.  Antimicrobial resistance in UK neonatal units: neonIN infection surveillance network.

Authors:  Benjamin Cailes; Christina Kortsalioudaki; Jim Buttery; Santosh Pattnayak; Anne Greenough; Jean Matthes; Alison Bedford Russell; Nigel Kennea; Paul T Heath
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2017-10-26       Impact factor: 5.747
View more
  5 in total

1.  Analysis of pathogens, drug resistance, sensitive antibiotic treatment and risk factors of early-onset sepsis in very low birth weight infants.

Authors:  Yingying Yu; Qikun Huang; Anchang Liu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 2.  Association of Infection in Neonates and Long-Term Neurodevelopmental Outcome.

Authors:  Elizabeth Sewell; Jessica Roberts; Sagori Mukhopadhyay
Journal:  Clin Perinatol       Date:  2021-06       Impact factor: 2.642

3.  Antibiotic Resistance Patterns of Bacterial Isolates from Neonatal Sepsis Patients at University Hospital of Leipzig, Germany.

Authors:  Belay Tessema; Norman Lippmann; Matthias Knüpfer; Ulrich Sack; Brigitte König
Journal:  Antibiotics (Basel)       Date:  2021-03-19

4.  Bacterial Pathogens and Evaluation of a Cut-Off for Defining Early and Late Neonatal Infection.

Authors:  Pavla Kucova; Lumir Kantor; Katerina Fiserova; Jakub Lasak; Magdalena Röderova; Milan Kolar
Journal:  Antibiotics (Basel)       Date:  2021-03-09

Review 5.  Neonatal intestinal dysbiosis.

Authors:  Mark A Underwood; Sagori Mukhopadhyay; Satyan Lakshminrusimha; Charles L Bevins
Journal:  J Perinatol       Date:  2020-09-23       Impact factor: 3.225
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.